Low-quality evidence found to support use of cannabinoids for CINV
the ONA take:
According to a study published in the Journal of the American Medical Association, researchers have found moderate-quality evidence to support the use of cannabinoids for the treatment of chronic pain and lower-quality evidence to support their use to treat chemotherapy-induced nausea and vomiting (CINV).
Cannabinoids are the active chemical compounds in marijuana.
For the study, researchers analyzed data from 79 trials that included 6,462 participants. Results of the meta-analysis showed that there was moderate-quality evidence to support the use of cannabinoids for the treatment of cancer pain. Researchers found low-quality evidence suggesting that cannabinoids improve CINV and very low-quality evidence to improve anxiety.
In regard to safety, cannabinoid use was associated with an increased risk of confusion, disorientation, dizziness, drowsiness, dry mouth, euphoria, fatigue, hallucination, loss of balance, nausea, and somnolence.
Moderate-quality evidence to support the use of cannabinoids for the treatment of chronic pain.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Refined Equation May Obviate Oncotype DX in Breast Cancer Treatment Decisions
- Risk Factors for Brain Metastases in HER2+ Breast Cancer Identified in Analysis
- Intermediate Oncotype DX Scores Prognostic of OS in Early-stage Breast Cancer
- Colorectal Cancer and Dietary Fiber: Source Is More Important Than Amount
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|